Hospital-based cross-sectional study to assess Vitamin D levels in patients of chronic spontaneous urticaria and its relation to severity of disease activity
{"title":"Hospital-based cross-sectional study to assess Vitamin D levels in patients of chronic spontaneous urticaria and its relation to severity of disease activity","authors":"Yashshavani Dass, D. Dogra, N. Dogra","doi":"10.25259/ijsa_11_2022","DOIUrl":null,"url":null,"abstract":"\n\nThe aim of this study was to assess and evaluate Vitamin D levels in CSU cases and compare with controls and to determine a correlation if any between Vitamin D levels and severity of CSU.\n\n\n\nA hospital-based case–control study of 130 cases and 130 controls was done. The assessment of severity of CSU was done using Urticaria Activity Score (UAS7). Laboratory investigations including Vitamin D levels were done in both groups.\n\n\n\nMean serum Vitamin D levels in cases and controls were 14.29 ng/ml and 28.8 ng/ml, respectively. Ninety-nine (76.2%) cases had deficient levels, 25 had insufficient levels, and six had normal levels. In controls, 63 had normal serum Vitamin D levels, 46 had insufficient, and 21 (16.1%) had deficient levels (t = −13.2340; P < 0.001). Cases with Vitamin D levels <10 ng/ml, 10–20 ng/ml, 20–30 ng/ml, and >30 ng/ml had mean UAS score of 18, 15.17, 7.28, and 6.67, respectively.\n\n\n\nIn this study, deficient Vitamin D levels were more commonly seen in cases as compared to controls and correlated inversely with the severity of disease as measured by UAS7. Vitamin D might be one among the multiple factors involved in etiopathogenesis/exacerbation of CSU or may be an outcome of the disease process. Adding Vitamin D supplements may improve clinical outcome in patients of CSU and reduce use of corticosteroids and immunosuppressive.\n","PeriodicalId":340475,"journal":{"name":"Indian Journal of Skin Allergy","volume":"333 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Skin Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ijsa_11_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The aim of this study was to assess and evaluate Vitamin D levels in CSU cases and compare with controls and to determine a correlation if any between Vitamin D levels and severity of CSU.
A hospital-based case–control study of 130 cases and 130 controls was done. The assessment of severity of CSU was done using Urticaria Activity Score (UAS7). Laboratory investigations including Vitamin D levels were done in both groups.
Mean serum Vitamin D levels in cases and controls were 14.29 ng/ml and 28.8 ng/ml, respectively. Ninety-nine (76.2%) cases had deficient levels, 25 had insufficient levels, and six had normal levels. In controls, 63 had normal serum Vitamin D levels, 46 had insufficient, and 21 (16.1%) had deficient levels (t = −13.2340; P < 0.001). Cases with Vitamin D levels <10 ng/ml, 10–20 ng/ml, 20–30 ng/ml, and >30 ng/ml had mean UAS score of 18, 15.17, 7.28, and 6.67, respectively.
In this study, deficient Vitamin D levels were more commonly seen in cases as compared to controls and correlated inversely with the severity of disease as measured by UAS7. Vitamin D might be one among the multiple factors involved in etiopathogenesis/exacerbation of CSU or may be an outcome of the disease process. Adding Vitamin D supplements may improve clinical outcome in patients of CSU and reduce use of corticosteroids and immunosuppressive.